Integra Lifesciences Holdings Corp (NAS:IART)
$ 29.62 0.73 (2.53%) Market Cap: 2.33 Bil Enterprise Value: 1.78 Bil PE Ratio: 59.20 PB Ratio: 0.80 GF Score: 77/100

Integra Lifesciences Holdings Corp at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 02:30PM GMT
Release Date Price: $61.05 (+1.01%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Let's go ahead and get started here. My name is David Lewis, Medical Device Analyst for Morgan Stanley. It's my pleasure to have with us here, as we progress through the morning in our first day of our conference, Integra Lifesciences.

And we've got 2 members of management, Peter Arduini, CEO; and Carrie Anderson, recently hired CFO. So we're going to jump right into it. Once again, please go to Morgan Stanley research disclosures website to see fun and familiar facts about me.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

So Pete, I want to move right into a soup question. You've talked about this business as a 5% to 7% grower for a prolonged period of time. We didn't see that level of growth in '17, '18 or the early part here of '19. What has held the company back in terms of getting into that sort of 5% to 7% profile?

Peter J. Arduini
Integra LifeSciences Holdings Corporation - President, CEO & Director

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot